CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3]

NCT06607393 · clinicaltrials.gov ↗

COMPLETED

Status

851

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Nonsmall Cell Lung Cancer

Interventions

DRUG: Pembrolizumab
DRUG: Pemetrexed
DRUG: Cisplatin
DRUG: Carboplatin

Sponsor

Aetion, Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]